Literature DB >> 17180613

Multifocal ERG findings in carriers of X-linked retinoschisis.

Linda S Kim1, William Seiple, Gerald A Fishman, Janet P Szlyk.   

Abstract

PURPOSE: To determine whether retinal dysfunction in obligate carriers of X-linked retinoschisis (XLRS) could be observed in local electroretinographic responses obtained with the multifocal electroretinogram (mfERG).
METHODS: Nine obligate carriers of XLRS (mean age, 46.2 years) were examined for the study. Examination of each carrier included an ocular examination and mfERG testing. For the mfERG, we used a 103-scaled hexagonal stimulus array that subtended a retinal area of approximately 40 degrees in diameter. The amplitudes and implicit times in each location for the mfERG were compared with the corresponding values determined for a group of 34 normally-sighted, age-similar control subjects.
RESULTS: Mapping of 103 local electroretinographic response amplitudes and implicit times within a central 40 degrees area with the mfERG showed regions of reduced mfERG amplitudes and delayed implicit times in two of nine carriers.
CONCLUSIONS: The mfERG demonstrated areas of retinal dysfunction in two carriers of XLRS. When present, retinal dysfunction was evident in the presence of a normal-appearing fundus. Multifocal ERG testing can be useful for identifying some carriers of XLRS.

Entities:  

Mesh:

Year:  2006        PMID: 17180613      PMCID: PMC1784540          DOI: 10.1007/s10633-006-9034-9

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


Introduction

Juvenile X-linked retinoschisis (XLRS) is a hereditary, vitreoretinal degeneration that was initially described in 1898 by Haas [1] and subsequently recognized to have an X-linked recessive inheritance in 1938 by Mann and Mac Rae [2]. It is characterized by decreased visual acuity within the first to second decade of life and cystic-appearing lesions within the fovea [3-5]. Approximately 50% of patients will also show peripheral retinoschisis [3-5]. A selective or predominant b-wave amplitude reduction on full-field electroretinogram (ERG) testing is a distinctive feature of the disease [6]. In other X-linked diseases, such as X-linked retinitis pigmentosa, choroideremia and X-linked ocular albinism, because of the principle of Lyonisation, which predicts a random inactivation of one X chromosome within each cell, female carriers can express some features of the diseases [7-9]. As a rule, female carriers of XLRS do not exhibit any clinically apparent fundus abnormalities [3, 4]. Isolated observations of foveal cystic-appearing lesions in female carriers from families with XLRS have been reported. There were six such female carriers noted out of a total of 13 who were examined in two different families with consanguineous marriages reported by two previous studies [10, 11]. Foveal changes, described as wrinkling of the internal limiting membrane, of one eye was reported in one female XLRS carrier from a non-consanguineous marriage by Wu et al. [12]. One study did find that 11 out of 11 obligate carriers showed an abnormal rod-cone interaction by psychophysical testing [13]. Nevertheless, carrier detection of XLRS currently can most reliably be successful by identifying genetic mutations in a gene that codes for a protein referred to as retinoschisin (RS1) [14, 15]. In the current study, we evaluated the possible role of multifocal ERG (mfERG) testing as a means of detecting functional abnormalities in obligate carriers of XLRS.

Methods

Nine obligate carriers (eight parents, one offspring) of XLRS patients were enrolled in the study. They were selected on the basis of their availability and willingness to participate in the study. Each had at least one male family member who was diagnosed as having characteristic XLRS findings by one of the authors (GAF). Five of the nine XLRS patients were confirmed as having the causative gene RS1. None of the carriers had any other medical or ocular conditions that might have affected their retinal function. After each carrier was counseled regarding the study, they signed a written informed consent approved by the Institutional Review Board at the University of Illinois at Chicago. The examinations were conducted in accordance with Health Insurance Portability and Accountability Act regulations. All carriers were examined at the Department of Ophthalmology, University of Illinois at Chicago by two of the authors (GAF, LSK). Best-corrected visual acuity (BCVA) was measured in each carrier with a Snellen projection chart. A dilated fundus examination and slit-lamp biomicroscopy of the lens and anterior segment of both eyes were performed on all carriers as were mfERG (Electro-Diagnostic Imaging, San Mateo, CA) measurements. Multiple retinal areas were stimulated to record local cone responses using a stimulus array of 103-scaled hexagons subtending a retinal area of approximately 40° in diameter. Each hexagon was scaled with eccentricity to obtain approximately equal amplitudes of local ERG responses [16]. The luminance of each hexagon was modulated according to a binary m-sequence. Individual stimulus elements were modulated between black (0.45 cd/m2) and white (280 cd/m2) for a time averaged luminance of 140.23 cd/m2 (approximately 3.8 log td). The surround luminance was set at 140 cd/m2. The stimulus was displayed on a black-and-white monitor driven at a frame rate of 75 Hz (Nortec, Plymouth, MN). Each subject’s vision was optimally corrected with a refractor/camera system for the fixed viewing distance of 40 cm. To ensure equal magnification of the stimulus array, the distance between a subject’s eye and the refractor/camera was adjusted for each subject to obtain a sharp image on a control monitor. Each carrier’s pupil was dilated with 2.5% phenylephrine and 1% tropicamide to obtain a pupil diameter of at least 7 mm. Multifocal ERGs were recorded only for the right eye for each of the XLRS carriers. A Burian-Allen bipolar contact lens electrode (Hansen Ophthalmic Laboratories, Iowa City, IA) was used and grounded to the ipsilateral ear. Before insertion of the contact lens electrode, a carrier’s cornea was anesthetized with 0.5% proparacaine, and the left eye was occluded. The total recording time was approximately 8 min divided into 32 segments. All carriers were required to maintain fixation during each of 14 sec segments. Segments with large eye movements, losses of fixation, or blinks were discarded and re-recorded. The raw data were filtered at a bandpass of 10 to 300 Hz, amplified at a gain of 100,000 (Astro-Med/Gass model CP11 amplifier), and digitized at 1200 Hz. Each local response was isolated by a cross correlation between the m-sequence and response cycle according to the VERIS algorithm. The amplitude (a-scale) and implicit time (t-scale) of all local (first-order) mfERG responses were derived using the algorithm of Hood and Li [17]. For the current analysis, raw waveforms were exported from the VERIS 3.0 for each of the 34 (15 male, 19 female) age-similar (30–79 years) normally sighted control subjects. Artifact reject and averaging with neighbors were turned off. Template wave forms were constructed for each hexagon from the average of all the control subjects’ data. These averaged templates were fitted using a least-squares fitting procedure to each control subject’s data by stretching horizontally (timing) and vertically (amplitude). For each hexagon, the a-scale values were then averaged across all normal subjects and standard deviations calculated. This was also done separately for the t-scale values. Each carrier’s data were then fit by the control templates and the resulting values for the a-scale and t-scale were plotted for each hexagon. For the a-scale, a number less than one indicates an amplitude lower than for the average control subjects and for the t-scale, a number greater than one indicates a timing delayed compared to the average control subjects. The statistical probability of each value was calculated using the control subjects mean and ±3 standard deviations (SD) for the a-scale and t-scale respectively and at each hexagon. The grey hexagons indicate >3 SD above the normal mean. For the 99.7% confidence level (grey hexagons) five control subjects had one abnormal amplitude and two subjects had two abnormal grey hexagons on the a-scale. For implicit time, six control subjects had one abnormal grey hexagon and two had two abnormal grey hexagons. Therefore, for this analysis, any carrier exhibiting a total of three or more grey hexagons were considered abnormal. A black hexagon indicated that a measurable signal could not be detected from the noise level. None of the 34 control subjects had any hexagons that were depicted as black. We used a criterion of two or more black hexagons for a carrier as highly likely to represent a local abnormality.

Results

The nine XLRS carriers ranged in age from 23–70 years, with a mean age of 46.2 years. All showed a normal exam of the anterior segment of the eye, including the lens. Visual acuity was 20/25 or better in each eye. None showed any fundus abnormalities. These findings are summarized in Table 1. Seven of the nine obligate carriers were observed to have varying degrees, from mild to moderate, of situs inversus of their temporal retinal vessels. In ocular situs inversus, the temporal vessels leave the optic disc directed towards the nasal retina before making a sharp temporal turn. The fundus photograph for Carrier #1 with situs inversus is shown in Fig. 1. In a study of fundus findings for XLRS patients, situs inversus was observed in 32% of patients with XLRS [18]. To our knowledge, situs inversus of the retinal vessels has not been emphasized as a possible finding in carriers of XLRS.
Table 1

The age, visual acuity for the right eye (OD) and left eye (OS) and fundus findings for each of the X-linked retinoschisis carriers

CarrierAge (years)VA ODVA OSFundus findings
13520/1520/15Mild situs inversus OU
24720/2020/20Normal OU
32320/2020/20 −1Normal OU
45320/2020/20Mild situs inversus OU
54820/2520/20Situs inversus OU
65820/2020/20Situs inversus OU
73920/2020/20Mild situs inversus OU
84320/20 −220/20Situs inversus inferior vein OS, anomalous branching OS > OD
97020/20 −220/20 −2Anomalous branching OU, situs inversus superior artery OD, inferior artery OS
Fig. 1

Fundus photograph of XLRS carrier #1 demonstrating situs inversus of the retinal veins

The age, visual acuity for the right eye (OD) and left eye (OS) and fundus findings for each of the X-linked retinoschisis carriers Fundus photograph of XLRS carrier #1 demonstrating situs inversus of the retinal veins Two of nine carriers demonstrated a mosaic pattern of statistically significant amplitude reductions (Figs. 2a, 3a) and implicit time delays (Figs. 2b, 3b). The actual mfERG tracings and hexagon analysis for these two carriers are shown in Figs. 2 and 3.
Fig. 2

Multifocal electroretinogram (mfERG) results of X-linked retinoschisis (XLRS) carrier #8 exhibiting a mosaic pattern of retinal dysfunction. MfERG amplitudes (a) and implicit times (b) for the right eye. In this figure, as in figure 3, the white hexagons show regions falling within 2 standard deviations (SD) of the normal mean. The grey hexagons represent locations that are more than 3 SD from the normal mean while the black hexagons indicate a non-measurable response. MfERG waveform traces are illustrated below (c)

Fig. 3

Multifocal electroretinogram (mfERG) results of XLRS carrier #3 exhibiting a mosaic pattern of retinal dysfunction. MfERG amplitudes (a) and implicit times (b) for the right eye. MfERG waveform traces are illustrated below (c)

Multifocal electroretinogram (mfERG) results of X-linked retinoschisis (XLRS) carrier #8 exhibiting a mosaic pattern of retinal dysfunction. MfERG amplitudes (a) and implicit times (b) for the right eye. In this figure, as in figure 3, the white hexagons show regions falling within 2 standard deviations (SD) of the normal mean. The grey hexagons represent locations that are more than 3 SD from the normal mean while the black hexagons indicate a non-measurable response. MfERG waveform traces are illustrated below (c) Multifocal electroretinogram (mfERG) results of XLRS carrier #3 exhibiting a mosaic pattern of retinal dysfunction. MfERG amplitudes (a) and implicit times (b) for the right eye. MfERG waveform traces are illustrated below (c)

Discussion

Our findings support the conclusion that the presence of a functional abnormality on mfERG testing, in the absence of other causes for retinal dysfunction in a female at risk, should suggest the presence of a carrier state for XLRS, which could then be further confirmed by genetic testing. However, a normal mfERG result would not, by itself, rule out the carrier state. Piao and co-workers [19] showed that mfERG cone-mediated responses were more impaired centrally than in the more peripheral retina in their study of seven male patients with XLRS. They also observed a higher frequency of delayed implicit times than reduced amplitudes in their patients. We did not observe either of these features in our two carriers. The presence of situs inversus of the retinal vessels in a female from a family with XLRS is also suggestive of the carrier state. Our findings on mfERG testing demonstrate the effect of Lyonisation on retinal function in carriers of XLRS. A similar finding on mfERG testing was observed in carriers of X-linked retinitis pigmentosa [20]. Multifocal ERG testing may be a useful technique for the detection and monitoring of localized retinal dysfunction in some carriers of XLRS.
  17 in total

1.  Multifocal electroretinograms in X-linked retinoschisis.

Authors:  Chang-Hua Piao; Mineo Kondo; Makoto Nakamura; Hiroko Terasaki; Yozo Miyake
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

2.  Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation.

Authors:  T Wang; A Zhou; C T Waters; E O'Connor; R J Read; D Trump
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  CONGENITAL VASCULAR VEILS IN THE VITREOUS.

Authors:  I Mann; A Macrae
Journal:  Br J Ophthalmol       Date:  1938-01       Impact factor: 4.638

4.  Positional cloning of the gene associated with X-linked juvenile retinoschisis.

Authors:  C G Sauer; A Gehrig; R Warneke-Wittstock; A Marquardt; C C Ewing; A Gibson; B Lorenz; B Jurklies; B H Weber
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

5.  The natural history of X-linked retinoschisis.

Authors:  M T Roesch; C C Ewing; A E Gibson; B H Weber
Journal:  Can J Ophthalmol       Date:  1998-04       Impact factor: 1.882

6.  X-linked retinoschisis in three females from the same family: a phenotype-genotype correlation.

Authors:  Francisco J Rodríguez; Alvaro Rodríguez; Roberto Mendoza-Londoño; Martha L Tamayo
Journal:  Retina       Date:  2005-01       Impact factor: 4.256

Review 7.  X linked retinoschisis.

Authors:  N D George; J R Yates; A T Moore
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

8.  A carrier state of X-linked juvenile retinoschisis.

Authors:  G Wu; E Cotlier; S Brodie
Journal:  Ophthalmic Paediatr Genet       Date:  1985-02

9.  X-chromosomal-linked diseases affecting the eye: status of the heterozygote female.

Authors:  A E Krill
Journal:  Trans Am Ophthalmol Soc       Date:  1969

10.  Fundus findings and longitudinal study of visual acuity loss in patients with X-linked retinoschisis.

Authors:  Marsha A Apushkin; Gerald A Fishman; Aruna S Rajagopalan
Journal:  Retina       Date:  2005 Jul-Aug       Impact factor: 4.256

View more
  8 in total

1.  The Role of X-Chromosome Inactivation in Retinal Development and Disease.

Authors:  Abigail T Fahim; Stephen P Daiger
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  Mouse models of X-linked juvenile retinoschisis have an early onset phenotype, the severity of which varies with genotype.

Authors:  Yang Liu; Junzo Kinoshita; Elena Ivanova; Duo Sun; Hong Li; Tara Liao; Jingtai Cao; Brent A Bell; Jacob M Wang; Yajun Tang; Susannah Brydges; Neal S Peachey; Botir T Sagdullaev; Carmelo Romano
Journal:  Hum Mol Genet       Date:  2019-09-15       Impact factor: 6.150

3.  R102W mutation in the RS1 gene responsible for retinoschisis and recurrent glaucoma.

Authors:  Xiu-Feng Huang; Chang-Sen Tu; Dong-Jun Xing; De-Kang Gan; Ge-Zhi Xu; Zi-Bing Jin
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

Review 4.  X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms.

Authors:  Robert S Molday; Ulrich Kellner; Bernhard H F Weber
Journal:  Prog Retin Eye Res       Date:  2012-01-03       Impact factor: 21.198

5.  Abnormal 8-Hz flicker electroretinograms in carriers of X-linked retinoschisis.

Authors:  J Jason McAnany; Jason C Park; Frederick T Collison; Gerald A Fishman; Edwin M Stone
Journal:  Doc Ophthalmol       Date:  2016-07-01       Impact factor: 2.379

6.  Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months.

Authors:  Mark E Pennesi; David G Birch; K Thiran Jayasundera; Maria Parker; Ou Tan; Rabia Gurses-Ozden; Carrie Reichley; Kathleen N Beasley; Paul Yang; Richard G Weleber; Lea D Bennett; John R Heckenlively; Kalyani Kothapalli; Jeffrey D Chulay
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-12-03       Impact factor: 4.799

Review 7.  Approach to inherited retinal diseases.

Authors:  Dhanashree Ratra; Sengul Ozdek; Munispriyan Raviselvan; Sailaja Elchuri; Tarun Sharma
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

8.  A novel mutation in RS1 and clinical manifestations in a Chinese twin family with congenital retinoschisis.

Authors:  Xiao-Fang Wang; Fei-Fei Chen; Xin Zhou; Xin-Xuan Cheng; Zheng-Gao Xie
Journal:  Front Genet       Date:  2022-09-23       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.